The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Carcinogenesis

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CARCIN/17.3.585PMID 8631149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogens

  2005cited by this paper
• Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial

  2005cited by this paper
• Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats

  2004cited by this paper
• Tumor and serum tamoxifen concentrations in the athymic nude mouse

  2004cited by this paper
• The Royal Marsden Hospital pilot tamoxifen chemoprevention trial

  2004cited by this paper
• Tamoxifen induces short-term cumulative DNA damage and liver tumors in rats: promotion by phenobarbital.

  1995cited by this paper
• Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.

  1995cited by this paper
• DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems.

  1994cited by this paper
• Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats.

  1994cited by this paper
• Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes.

  1994cited by this paper
• Growth stimulation followed by growth inhibition in livers of female rats treated with ethinyl estradiol.

  1994cited by this paper
• Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450.

  1994cited by this paper
• Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.

  1993cited by this paper
• Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.

  1993cited by this paper
• Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.

  1993cited by this paper
• Induction of CYP2B1 and 3A1, and associated monoxygenase activities by tamoxifen and certain analogues in the livers of female rats and mice.

  1993cited by this paper
• The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat.

  1993cited by this paper
• A Risk-Benefit Assessment of Tamoxifen Therapy

  1993cited by this paper
• Measurement of ploidy and cell proliferation in the rodent liver.

  1993cited by this paper
• Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats.

  1993cited by this paper
• Cell proliferation and apoptosis in normal liver and preneoplastic foci.

  1993cited by this paper
• Tamoxifen--panacea or Pandora's box?

  1992cited by this paper
• Long-term prophylactic use of tamoxifen: is it safe?

  1992cited by this paper
• Induction of covalent DNA adducts in rodents by tamoxifen.

  1992cited by this paper
• The effects of diethylstilbestrol, tamoxifen, and toremifene on estrogen-inducible hepatic proteins and estrogen receptor proteins in female rats.

  1992cited by this paper
• Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party.

  1992cited by this paper
• Should healthy women take tamoxifen?

  1992cited by this paper
• Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.

  1992cited by this paper
• Breast cancer prevention study initiated in Italy.

  1992cited by this paper
• Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

  1991cited by this paper
• Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse.

  1991cited by this paper
• Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.

  1991cited by this paper
• An initiation-promotion assay in rat liver as a potential complement to the 2-year carcinogenesis bioassay.

  1991cited by this paper
• Structural Requirements for the in vitro Transformation of Syrian Hamster Embryo Cells by Stilbene Estrogens and Triphenylethylene‐Type Antiestrogens

  1991cited by this paper
• Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.

  1991cited by this paper
• Cell proliferation and tumour promotion by ethinyl estradiol in rat hepatocarcinogenesis.

  1991cited by this paper
• Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.

  1991cited by this paper
• Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis.

  1991cited by this paper
• Long-term adjuvant tamoxifen therapy for breast cancer

  1990cited by this paper
• Endocrine pharmacology of antiestrogens as antitumor agents.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.

  1990cited by this paper
• Altered hepatic foci: their role in murine hepatocarcinogenesis.

  1990cited by this paper
• Tamoxifen for breast cancer: Associated endometrial cancer

  1990cited by this paper
• Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

  1990cited by this paper
• Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer.

  1990cited by this paper
• Tamoxifen metabolism: pharmacokinetic and in vitro study.

  1989cited by this paper
• Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations.

  1989cited by this paper
• A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

  1989cited by this paper
• Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents.

  1989cited by this paper
• Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes.

  1988cited by this paper
• Non-isomerisable antiestrogens related to tamoxifen.

  1988cited by this paper
• Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

  1988cited by this paper
• Inhibitory Effect of Tamoxifen on Diethylstilbestrol‐promoted Hepatic Tumorigenesis in Male Rats and Its Possible Mechanism of Action

  1988cited by this paper
• Rapid stimulation of liver palmitoyl-CoA synthetase, carnitine palmitoyltransferase and glycerophosphate acyltransferase compared to peroxisomal beta-oxidation and palmitoyl-CoA hydrolase in rats fed high-fat diets.

  1988cited by this paper
• Tamoxifen and benign breast problems.

  1987cited by this paper
• Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM).

  1987cited by this paper
• Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat.

  1987cited by this paper
• Synthesis and Estrogen Receptor Binding of 6,7-Dihydro-8-phenyl-9-(4(2-(dimethylamino)ethoxy)phenyl)-5H-benzocycloheptene, a Nonisomerizable Analogue of Tamoxifen. X-Ray Crystallographic Studies.

  1987cited by this paper
• Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.

  1986cited by this paper
• Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.

  1986cited by this paper
• Synthesis and estrogen receptor binding of 6,7-dihydro-8-phenyl-9-[4-[2-(dimethylamino)ethoxy] phenyl]-5H-benzocycloheptene, a nonisomerizable analogue of tamoxifen. X-ray crystallographic studies.

  1986cited by this paper
• Modification of the basic side chain in tamoxifen: effects on microsomal metabolism and in vitro biological activity.

  1986cited by this paper
• Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver.

  1986cited by this paper
• Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase-positive foci in female rats.

  1986cited by this paper
• A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.

  1986cited by this paper
• Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis.

  1985cited by this paper
• Tumor promotion in the liver

  1985cited by this paper
• Facile geometric isomerization of phenolic non-steroidal estrogens and antiestrogens: limitations to the interpretation of experiments characterizing the activity of individual isomers.

  1985cited by this paper
• Long-term tamoxifen adjuvant therapy in node-positive breast cancer: A metabolic and pilot clinical study

  1984cited by this paper
• Analysis of Tamoxifen and its Metabolites

  1984cited by this paper
• The pharmacology and clinical uses of tamoxifen.

  1984cited by this paper
• Safety testing of new drugs : laboratory predictions and clinical performance

  1984cited by this paper
• Comparison of formalin- and acetone-fixation for immunohistochemical detection of carcinoembryonic antigen (CEA) and keratin.

  1983cited by this paper
• Determination of tamoxifen and metabolites in human serum by high-performance liquid chromatography with post-column fluorescence activation.

  1983cited by this paper
• Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver.

  1982cited by this paper
• Role of estrogens as promoters of hepatic neoplasia.

  1982cited by this paper
• A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women.

  1982cited by this paper
• VITAMIN E DEFICIENCY AS HEPATIC PEROXISOMAL PROLIFERATOR: QUALITATIVE AND QUANTITATIVE ELECTRON MICROSCOPIC STUDY

  1982cited by this paper
• Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen.

  1982cited by this paper
• A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

  1981cited by this paper
• Assay of peroxisomal beta-oxidation of fatty acids.

  1981cited by this paper
• Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma.

  1981cited by this paper
• Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.

  1980cited by this paper
• Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast.

  1978cited by this paper
• Biochemical characterisation of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine

  1978cited by this paper
• The effect of estradiol‐17‐phenylpropionate and estradiol benzoate on N‐nitrosomorpholine‐induced liver carcinogenesis in ovariectomized female rats

  1978cited by this paper
• A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.

  1977cited by this paper
• Regression of liver cell adenomas associated with oral contraceptives.

  1977cited by this paper
• Evaluation of tamoxifen dose in advanced breast cancer: a progress report.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Report of a workshop on classification of specific hepatocellular lesions in rats.

  1975cited by this paper
• Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes.

  1974cited by this paper
• The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals.

  1973cited by this paper
• Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

  1973cited by this paper
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

  1971cited by this paper
• Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

  1966cited by this paper

• Protective role of olive oil extract of propolis on short and long‐term administration of tamoxifen in rats

  2023cites this paper
• Customizable Microfluidic Origami Liver‐on‐a‐Chip (oLOC)

  2022cites this paper
• South to Northwestern in Chicago

  2022cites this paper
• The good, the bad and the ugly of tamoxifen at Wisconsin

  2022cites this paper
• Chemical carcinogens and their effect on genome and epigenome stability

  2021cites this paper
• The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture

  2019cites this paper
• Osthole prevents tamoxifen-induced liver injury in mice

  2018cites this paper
• Black Seed (Nigella Sativa) and its Constituent Thymoquinone as an Antidote or a Protective Agent Against Natural or Chemical Toxicities

  2017cites this paper
• Sodium Butyrate Attenuates Nephrotoxicity Induced by Tamoxifen in Rats.

  2016cites this paper
• Protective role of thymoquinone against liver damage induced by tamoxifen in female rats.

  2014cites this paper
• Identification of Compounds by High-Content Screening That Induce Cytoplasmic to Nuclear Localization of a Fluorescent Estrogen Receptor α Chimera and Exhibit Agonist or Antagonist Activity In Vitro

  2014cites this paper
• Alterations in Histone H4 Lysine 20 Methylation: Implications for Cancer Detection and Prevention

  2012cites this paper
• Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case report.

  2012cites this paper
• Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen

  2012cites this paper
• Development of an image analysis screen for estrogen receptor alpha (ERα) ligands through measurement of nuclear translocation dynamics.

  2010cites this paper
• Evaluation of oxidative stress and antioxidative action of green tea catechins in patients treated with tamoxifen: a randomized open-label, crossover study

  2010cites this paper
• Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats.

  2009cites this paper
• The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat

  2009cites this paper
• A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance

  2008cites this paper
• Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice

  2007cites this paper
• Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure.

  2007cites this paper
• 8.08 – Tamoxifen

  2007cites this paper
• Epigenetic reprogramming of liver cells in tamoxifen‐induced rat hepatocarcinogenesis

  2007cites this paper
• Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.

  2007influential citation
• Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis.

  2007cites this paper
• Toremifene: an evaluation of its safety profile.

  2006cites this paper
• Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice.

  2006cites this paper
• Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice.

  2006cites this paper
• Estrogen receptors as therapeutic targets in breast cancer.

  2006cites this paper
• Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis.

  2005cites this paper
• Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

  2003cites this paper
• On the Promoting Action of Tamoxifen in the P-Dimethylaminoazobenzene Induced Hepatocarcinogenesis CF1 Mice Model and the Cytoprotective Role of Heme Oxygenase

  2002cites this paper
• On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice.

  2001cites this paper
• Selective Estrogen Receptor Modulation

  2001cites this paper
• Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis

  2000cites this paper
• Tamoxifen inhibits acidification in cells independent of the estrogen receptor.

  1999cites this paper
• Pharmacology and Use of Antiestrogens in Treatment and Chemoprevention of Breast Cancer

  1999cites this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cites this paper
• Molecular mechanisms and future uses of antiestrogens.

  1997cites this paper